Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.
Under an alliance framework with AstraZeneca, Merck, and Eli Lilly and Company leading as founding participants, the Atlas is ...
Explore the innovative generative AI method transforming drug discovery and material science at unprecedented speeds.
The San Diego firm took a step in that direction on Tuesday, when it unveiled what it says will be the world’s largest ...
Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.
PHILADELPHIA, Nov. 12, 2025 /PRNewswire/ -- Cell Surface Bio (CSB) announces the launch VeRSa-Select™, a custom antibody service providing scientists with unparalleled access to the highest quality ...
Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene ...
One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, according to a new study published November 5, 2025, in npj Precision Oncology ...
For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...
Identifying the mechanisms of action driving a drug’s anti-cancer efficacy is critical for identifying optimal biomarkers, indications, and combinations for clinical success. Yet, systematically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results